Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

13.5K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.5K
  1. Home
  3. Research Domains
  5. Chemical Sciences
  7. Analytical Chemistry
  9. Instrumental Methods (excl. Immunological And Bioassay Methods)
  11. Reducing Oxidative Stress-mediated Alcoholic Liver Injury By Multiplexed Rnai Of Cyp2e1, Cyp4a10, And Cyp4a14.
  1. Home
  3. Research Domains
  5. Chemical Sciences
  7. Analytical Chemistry
  9. Instrumental Methods (excl. Immunological And Bioassay Methods)
  11. Reducing Oxidative Stress-mediated Alcoholic Liver Injury By Multiplexed Rnai Of Cyp2e1, Cyp4a10, And Cyp4a14.

Related Experiment Video

Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
08:37

Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer

Published on: November 15, 2024

314

Reducing Oxidative Stress-Mediated Alcoholic Liver Injury by Multiplexed RNAi of Cyp2e1, Cyp4a10, and Cyp4a14.

Qi Zhang1, Shuang Wu1, Qiubing Chen2,3

  • 1School of Pharmacy, Jiangsu University, Zhenjiang 212013, China.

Biomedicines
|July 27, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

This study shows that a triple siRNA therapy targeting Cyp2e1, Cyp4a10, and Cyp4a14 effectively treats alcoholic liver disease (ALD) in mice. Early intervention with this RNA interference approach significantly reduced liver injury and oxidative stress.

Keywords:
alcoholic liver diseasecytochrome P450sferroptosisin vivo RNAi

More Related Videos

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

7.8K
Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration
05:37

Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration

Published on: May 31, 2018

12.1K

Related Experiment Videos

Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
08:37

Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer

Published on: November 15, 2024

314
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

7.8K
Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration
05:37

Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration

Published on: May 31, 2018

12.1K

Area of Science:

  • Hepatology
  • Molecular Biology
  • Pharmacology

Background:

  • Alcoholic liver disease (ALD) prevalence is increasing, with limited therapeutic options.
  • Oxidative stress from alcohol metabolism, particularly via cytochrome P450 enzymes, drives hepatocyte damage.
  • Previous studies indicated Cyp2e1 inhibition reduces ALD, but compensatory oxidative stress mechanisms persist.

Purpose of the Study:

  • To investigate the therapeutic potential of a combined siRNA targeting Cyp2e1, Cyp4a10, and Cyp4a14 in ALD mouse models.
  • To evaluate the efficacy of this triple siRNA therapy at different treatment stages (early, middle, late).
  • To elucidate the underlying mechanisms of action, including effects on oxidative stress, inflammation, and lipid metabolism.

Main Methods:

  • Development and administration of triple siRNA lipid nanoparticles (LNPs) targeting Cyp2e1, Cyp4a10, and Cyp4a14.
inflammation
  • Treatment of chronic alcoholic liver injury mouse models using the Lieber-Decarli ethanol liquid diet.
  • Assessment of therapeutic effects at early (1 week), middle (5 weeks), and late (9 weeks) stages of the diet.
  • Analysis of gene expression related to oxidative stress, antioxidant defense, inflammation, and lipid metabolism.

    • Main Results:

    • Triple siRNA LNPs significantly ameliorated chronic alcoholic liver injury, with early treatment yielding the most significant benefits.
    • Treatment reduced oxidative stress and enhanced the expression of antioxidant genes (Gsh-Px, Gsh-Rd, Sod1).
    • Inflammation markers (Il-1β, Il-6, Tnf-α, Tgf-β) were downregulated, and lipid synthesis regulators (Srebp1c, Acc, Fas) were restored, indicating improved lipid metabolism and oxidation.

    Conclusions:

    • Combined in vivo knockdown of Cyp2e1, Cyp4a10, and Cyp4a14 using triple siRNA LNPs is a promising therapeutic strategy for ALD.
    • Early intervention is crucial for maximizing the therapeutic benefits of this approach.
    • The therapy effectively mitigates oxidative stress, inflammation, and aberrant lipid metabolism in ALD.